Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma

Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for ad ...